Q45L (p.Gln45Leu) variant of FBN2 (Fibrillin-2)

Q45L (p.Gln45Leu) in FBN2 (Fibrillin-2) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.37 / 1. The record also includes published literature and structural context.

Q45L (p.Gln45Leu) variant details